Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share...